Monday - December 23, 2024

(3aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8ahexahydropyrrolo[2,3-B]indol-5-Yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration

2024-11-19

ALEXANDRIA, Virginia, Nov. 19 -- ANNOVIS BIO, INC., Berwyn, Pennsylvania has been assigned a patent (No. US 12144798 B2, initially filed June 7, 2022) developed by Maria Maccecchini, West Chester, Pennsylvania, for "(3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8ahexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegeneration." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

(3aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8ahexahydropyrrolo[2,3-B]indol-5-Yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration

Information Request Form

Copyright Targeted News Service 2024